Urinary symptoms as a predictor for participation in prostate cancer screening among African American men

被引:0
作者
Weinrich, SP [1 ]
Weinrich, M
Mettlin, C
Reynolds, WA
Wofford, JE
机构
[1] Univ S Carolina, Coll Nursing, Columbia, SC 29208 USA
[2] Univ S Carolina, Sch Publ Hlth, Columbia, SC 29208 USA
[3] Columbia Urol Associates, Columbia, SC USA
[4] Roswell Pk Canc Inst, Buffalo, NY USA
关键词
urinary symptoms; prostatic neoplasms; African American men; screening;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. There are minimal data on the influence of urinary symptoms and participation in prostate cancer screening in African American men. METHODS. This correlational study examined the influence of urinary symptoms on 1) participation in a free prostate cancer screening program and 2) abnormal screening results. The 1,402 African American men in the South Carolina Prostate Cancer Project (SCPCP), mean age of 50 years, completed a survey that included self-reported urinary symptoms, participated in a prostate cancer educational program, and received a free prostate cancer screening consisting of a digital rectal examination (DRE) and prostate-specific antigen (PSA) from their personal physician. RESULTS. One in 5 men reported the presence of urinary symptoms. Over 60% of the 1,402 men participated in the free CaP screening. Among the 852 men who participated in the fr ee prostate cancer screening, 73 (8.6%) had abnormal screening results as classified by abnormal DRE and/or PSA > 4.0 ng/ml. Urinary symptoms were significant predictors, both of participation in screening (OR = 1.30, CI = 1.00, 1.70) and of obtaining an abnormal screening result (OR = 1.78, CI = 1.17, 2.72). CONCLUSIONS. Prostate cancer health education needs to include the fact that prostate cancer, in its early stages, has no urinary symptoms. (C) 1998 Wiley-Liss, Inc.
引用
收藏
页码:215 / 222
页数:8
相关论文
共 47 条
[1]  
[Anonymous], 1989, SAS STAT US GUID VER
[2]   THE AMERICAN-UROLOGICAL-ASSOCIATION SYMPTOM INDEX FOR BENIGN PROSTATIC HYPERPLASIA [J].
BARRY, MJ ;
FOWLER, FJ ;
OLEARY, MP ;
BRUSKEWITZ, RC ;
HOLTGREWE, HL ;
MEBUST, WK ;
COCKETT, ATK ;
BLAIVAS, JG ;
WEIN, AJ .
JOURNAL OF UROLOGY, 1992, 148 (05) :1549-1557
[3]   SCREENING FOR PROSTATIC-CARCINOMA WITH PROSTATE SPECIFIC ANTIGEN [J].
BRAWER, MK ;
CHETNER, MP ;
BEATIE, J ;
BUCHNER, DM ;
VESSELLA, RL ;
LANGE, PH .
JOURNAL OF UROLOGY, 1992, 147 (03) :841-845
[4]   MEASUREMENT OF PROSTATE-SPECIFIC ANTIGEN IN SERUM AS A SCREENING-TEST FOR PROSTATE-CANCER [J].
CATALONA, WJ ;
SMITH, DS ;
RATLIFF, TL ;
DODDS, KM ;
COPLEN, DE ;
YUAN, JJJ ;
PETROS, JA ;
ANDRIOLE, GL .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) :1156-1161
[5]   COMPARISON OF DIGITAL RECTAL EXAMINATION AND SERUM PROSTATE-SPECIFIC ANTIGEN IN THE EARLY DETECTION OF PROSTATE-CANCER - RESULTS OF A MULTICENTER CLINICAL-TRIAL OF 6,630 MEN [J].
CATALONA, WJ ;
RICHIE, JP ;
AHMANN, FR ;
HUDSON, MA ;
SCARDINO, PT ;
FLANIGAN, RC ;
DEKERNION, JB ;
RATLIFF, TL ;
KAVOUSSI, LR ;
DALKIN, BL ;
WATERS, WB ;
MACFARLANE, MT ;
SOUTHWICK, PC .
JOURNAL OF UROLOGY, 1994, 151 (05) :1283-1290
[6]   THE PREVALENCE OF PROSTATISM - A POPULATION-BASED SURVEY OF URINARY SYMPTOMS [J].
CHUTE, CG ;
PANSER, LA ;
GIRMAN, CJ ;
OESTERLING, JE ;
GUESS, HA ;
JACOBSEN, SJ ;
LIEBER, MM .
JOURNAL OF UROLOGY, 1993, 150 (01) :85-89
[7]   Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study [J].
DeAntoni, EP ;
Crawford, ED ;
Oesterling, JE ;
Ross, CA ;
Berger, ER ;
McLeod, DG ;
Staggers, F ;
Stone, NN .
UROLOGY, 1996, 48 (02) :234-239
[8]  
DeAntoni EP, 1997, CANCER-AM CANCER SOC, V80, P1845, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1845::AID-CNCR24>3.0.CO
[9]  
2-4
[10]  
DEANTONI EP, 1995, CANCER, V75, P1874, DOI 10.1002/1097-0142(19950401)75:7+<1874::AID-CNCR2820751618>3.0.CO